1,4,7-triazacyclononane-n,n',n''-triacetic acid has been researched along with Cancer of Ovary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, F; Cheng, C; Jiang, H; Liu, H; Liu, Q; Ma, C; Pan, D; Wang, L; Wang, T; Xu, Y; Yang, M; Yang, R; Zhang, A; Zhang, D; Zuo, C | 1 |
| Boerman, OC; Boschetti, F; Heskamp, S; Laverman, P; Oyen, WJ; Rosik, D; Tolmachev, V; van der Graaf, WT; van Laarhoven, HW | 1 |
2 other study(ies) available for 1,4,7-triazacyclononane-n,n',n''-triacetic acid and Cancer of Ovary
| Article | Year |
|---|---|
Targeting of MMP2 activity in malignant tumors with a 68Ga-labeled gelatinase inhibitor cyclic peptide.
Topics: Animals; Female; Gallium Radioisotopes; Gelatinases; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Immunoenzyme Techniques; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Peptides, Cyclic; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2015 |
Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer.
Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Disease Models, Animal; Female; Fluorine Radioisotopes; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Mice; Mice, Inbred BALB C; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Receptor, ErbB-2; Recombinant Fusion Proteins; Tomography, X-Ray Computed | 2012 |